Precision Psychiatry: How Far Off Are We?
Exploring the opportunities, challenges, and current research in lab-based testing for mental health disorders
Exploring the opportunities, challenges, and current research in lab-based testing for mental health disorders
From - Diagnostic Testing & Emerging Technologies
The vast majority of sudden infant death syndrome (SIDS) cases are not the result of genetic heart diseases (GHDs) or a single genetic cause…
From - Diagnostic Testing & Emerging Technologies
Researchers have developed the first multiplex array for diagnosis of tickborne diseases, according to a study published online…
From - Diagnostic Testing & Emerging Technologies
There is not enough evidence, currently, to support the routine adoption of liquid biopsy tests for any of its promising clinical uses, according to a joint review published…
From - Diagnostic Testing & Emerging Technologies
Several companies presented findings at the American Academy of Dermatology's annual meeting (Feb. 16-18, San Diego) indicating that…
From - Diagnostic Testing & Emerging Technologies
Dermatopathologists are increasingly using molecular testing for diagnosis of skin cancer samples. Yet, this adoption remains more concentrated in…
From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration (FDA) recently approved the first blood test to evaluate concussions in adults…
From - Diagnostic Testing & Emerging Technologies
A blood-based screening test capable of detecting multiple forms of early cancer just took one step closer to becoming a reality. A study published…
From - Diagnostic Testing & Emerging Technologies
In an era of growing concerns over antibiotic stewardship, there is renewed interest in delabeling misidentified penicillin allergies as part of quality improvement efforts…